LianBio is a biotechnology company based in Princeton, NJ, dedicated to bringing groundbreaking medicines to patients in China and major Asian markets. With a focus on disease relevance and precision-based therapeutics, LianBio collaborates with world-class partners to develop a diverse pipeline of transformative treatments across therapeutic areas such as oncology, ophthalmology, and inflammatory diseases.
Rooted in global scientific research, LianBio's mission is to accelerate the availability of paradigm-shifting medicines through strategic partnerships that provide access to the best science-driven therapeutic discoveries. By selecting programs with strong scientific foundations and clinical data, LianBio aims to make a significant impact on patients' lives in China and other Asian markets.
Generated from the website